Cognetivity Neurosciences Ltd.
CGN
CNSX
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 73.50K | 52.00K | 36.80K | 33.70K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 73.50K | 52.00K | 36.80K | 33.70K | -- |
| Cost of Revenue | 1.01M | 1.21M | 1.56M | 1.68M | 2.31M |
| Gross Profit | -937.10K | -1.15M | -1.53M | -1.65M | -2.31M |
| SG&A Expenses | 2.20M | 2.21M | 2.46M | 2.70M | 4.84M |
| Depreciation & Amortization | 19.50K | 19.30K | 18.90K | 18.90K | 21.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.23M | 3.88M | 4.54M | 4.87M | 7.86M |
| Operating Income | -3.16M | -3.83M | -4.50M | -4.83M | -7.86M |
| Income Before Tax | -6.41M | -6.26M | -6.04M | -5.66M | -7.86M |
| Income Tax Expenses | -- | -- | -- | -- | -9.40K |
| Earnings from Continuing Operations | -6.41 | -6.26 | -6.04 | -5.66 | -7.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.41M | -6.26M | -6.04M | -5.66M | -7.85M |
| EBIT | -3.16M | -3.83M | -4.50M | -4.83M | -7.86M |
| EBITDA | -3.14M | -3.81M | -4.48M | -4.81M | -7.83M |
| EPS Basic | -0.07 | -0.07 | -0.07 | -0.07 | -0.10 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.05 | -0.04 | -0.06 |
| EPS Diluted | -0.07 | -0.07 | -0.07 | -0.07 | -0.10 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.05 | -0.04 | -0.06 |
| Average Basic Shares Outstanding | 346.16M | 337.20M | 329.52M | 316.91M | 311.93M |
| Average Diluted Shares Outstanding | 346.16M | 337.20M | 329.52M | 316.91M | 311.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
